Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Syngene International Limited

Diagnostics & Research | Healthcare

Company Overview

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Key Information

Market Cap

271595175936

Current Price

676.0

52 Week Range

599.55 - 960.6

Previous Close

671.05

Open

674.0

Industry

Diagnostics & Research

Sector

Healthcare

Contact Details

Address

Biocon SEZ, Biocon Park, Plot No. 2 & 3 Bommasandra Industrial Area, IV Phase Jigani Link Road, Bengaluru, 560099, India

Phone

+91-80689-18000

Fax

+91-80689-18808

Website

https://www.syngeneintl.com

Financials

Day Low

661.95

Day High

686.5

Dividend Yield

0.19

PE Ratio

54.73684

Earnings Per Share

12.35

Beta

0.14

EBITDA

9912000512

Book Value

117.59

EPS

10.8913

Company Officers

Name	Title	Age	Year Born
Mr. Peter James Jonathan Bains	CEO, MD & Director	67	1957
Mr. Deepak Jain	Chief Financial Officer	-	-
Dr. Jayashree Aiyar Ph.D.	Chief Scientific Officer	-	-
Krishnan G	Head of Investor Relations	-	-
Mr. Sandeep Nair	Head of Corporate Communications	-	-
Mr. Andrew Webster	Chief Human Resources Officer	-	-
Dr. Dhananjay Patankar	Head of Pharmaceutical & Biopharmaceutical Development	-	-
Mr. Purushottam Shashikant Singnurkar	Head of Formulations Development	-	-
Mr. Ajit Manocha	Head of IT	-	-
Dr. Chetan Prakash Tamhankar	Head of Clinical Development & Stability Studies	-	-